COLLEEN KENNEDY SMITH: Open Payments
NPI 1750375911 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$143 in 7 payments from 7 companies in 2025. Trend: 2023 $16 · 2024 $108 · 2025 $143
Food & beverage: $143
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
Products named: DUPIXENT, XIFAXAN, LINZESS, TREMFYA, ENTYVIO, XELJANZ, IBSRELA.
Industry payments across NC — which companies pay providers there.
